相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers
Masanori Yoshimatsu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
Shinya Hayami et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors
Qiong Zhao et al.
LUNG CANCER (2011)
Distinctive Expression of the Polycomb Group Proteins Bmi1 Polycomb Ring Finger Oncogene and Enhancer of Zeste Homolog 2 in Nonsmall Cell Lung Cancers and Their Clinical and Clinicopathologic Significance
Junko Kikuchi et al.
CANCER (2010)
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer
Motoki Miyazawa et al.
CANCER SCIENCE (2010)
Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway
Shinya Hayami et al.
MOLECULAR CANCER (2010)
UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer
M. Unoki et al.
BRITISH JOURNAL OF CANCER (2009)
Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
O. Fluge et al.
BRITISH JOURNAL OF CANCER (2009)
Aurora kinases as anticancer drug targets
Oliver Gautschi et al.
CLINICAL CANCER RESEARCH (2008)
Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells
F. Pittella Silva et al.
ONCOGENE (2008)
Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas
Nobuhisa Ishikawa et al.
CANCER RESEARCH (2007)
The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3
Masaki Kunizaki et al.
CANCER RESEARCH (2007)
Target-based approach to inhibitors of histone arginine methyltransferases
Astrid Spannhoff et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
EZH2 promotes proliferation and invasiveness of prostate cancer cells
R. J. Bryant et al.
PROSTATE (2007)
Small molecule inhibitors of histone arginine methyltransferases: Homology modeling, molecular docking, binding mode analysis, and biological evaluations
Rino Ragno et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The control of histone lysine methylation in epigenetic regulation
Pamela Volkel et al.
BIOCHIMIE (2007)
Polycomb complexes repress developmental regulators in murine embryonic stem cells
LA Boyer et al.
NATURE (2006)
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
AP Bracken et al.
GENES & DEVELOPMENT (2006)
Control of developmental regulator's by polycomb in human embryonic stem cells
TI Lee et al.
CELL (2006)
Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer
K Collett et al.
CLINICAL CANCER RESEARCH (2006)
Enhanced SMYD3 expression is essential for the growth of breast cancer cells
R Hamamoto et al.
CANCER SCIENCE (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder
JD Raman et al.
CLINICAL CANCER RESEARCH (2005)
A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers
M Tsuge et al.
NATURE GENETICS (2005)
Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors
T Kusaba et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis
T Kato et al.
CANCER RESEARCH (2005)
Pharmacokinetic variability of anticancer agents
SD Undevia et al.
NATURE REVIEWS CANCER (2005)
Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays
G Callagy et al.
JOURNAL OF PATHOLOGY (2005)
Increased expression of EZH2, a polycomb group protein, in bladder carcinoma
S Arisan et al.
UROLOGIA INTERNATIONALIS (2005)
SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
R Hamamoto et al.
NATURE CELL BIOLOGY (2004)
ADAM8 as a novel serological and histochemical marker for lung cancer
N Ishikawa et al.
CLINICAL CANCER RESEARCH (2004)
Small molecule regulators of protein arginine methyltransferases
DH Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples
SF Chin et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2003)
Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs
T Kikuchi et al.
ONCOGENE (2003)
Molecular classification of breast carcinomas using tissue microarrays
G Callagy et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2003)
Programming off and on states in chromatin: mechanisms of Polycomb and trithorax group complexes
JA Simon et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
The Polycomb-group gene Ezh2 is required for early mouse development
D O'Carroll et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
